District Of Columbia is currently home to 920 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including Washington, Washington, D.C., Washington DC and Washington, Dc. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
Pregnancy and Early Neurodevelopmental Outcomes Following In Utero Lyme Disease Exposure
NCT06026969
Recruiting
The purpose of this pilot study is to assess the feasibility of longitudinal neurodevelopmental evaluation of fetuses and infants exposed to Lyme disease in utero. Participants with Lyme disease or Post-Treatment Lyme Disease Syndrome (PTLDS) will be recruited during pregnancy. Pregnancies will be monitored and infant development will be assessed from birth until age 18 months.
Gender:
All
Ages:
18 years and above
Trial Updated:
09/05/2023
Locations: Children's National Hospital, Washington, District of Columbia
Conditions: Lyme Disease, Post-Treatment Lyme Disease, Chronic Lyme Disease, Tick-Borne Infections, Pregnancy Complications, Child Development
Register for Updates
Erector Spinae Block for Thoracic Surgery
NCT05521789
Recruiting
The aim of this study is to determine if erector spinae injections with bolus infusions with local anesthetic decrease postsurgical pain and opioid consumption in patients undergoing pulmonary resection surgery.
Gender:
All
Ages:
Between 18 years and 90 years
Trial Updated:
09/05/2023
Locations: The George Washington University, Washington, District of Columbia
Conditions: Pulmonary Neoplasm, Pulmonary Cancer, Thoracic Diseases, Thoracic Cancer, Thoracic Neoplasms
Register for Updates
Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis
NCT05177107
Recruiting
This is a phase IIa randomized trial designed to evaluate bacteriophage therapy in patients with diabetic foot osteomyelitis.
Gender:
All
Ages:
Between 18 years and 85 years
Trial Updated:
09/05/2023
Locations: MedStar Washington Hospital Center, Washington, District of Columbia
Conditions: Osteomyelitis, Diabetic Foot Osteomyelitis
Register for Updates
Qualitative Assessment of the Impact of TTNS on QOL and Participation
NCT04248322
Recruiting
This study through the use of semi-structured interviews or focus groups will explore the lived experience with Transcutaneous Tibial Nerve Stimulation (TTNS) with Neurogenic Lower Urinary Tract Dysfunction to generate user-defined themes regarding bladder function and catheter-related barriers and the daily impacts on one's life.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
09/05/2023
Locations: MedStar National Rehabilitation Hospital, Washington, District of Columbia
Conditions: Neurogenic Bladder, Urinary Retention, Urinary Tract Infections, Spinal Cord Injuries
Register for Updates
Transvaginal Low-level Laser Therapy to Improve Pelvic Pain and Sexual Function in Patients With Endometriosis.
NCT05540353
Recruiting
Dyspareunia is defined as pain with penetrative sexual intercourse. Women with endometriosis have a nine-fold increased risk of dyspareunia, when compared to the general female population. A prospective single-blinded randomized controlled trial will be performed evaluating the change in pelvic pain and sexual satisfaction scores from baseline to 6 weeks after treatment with transvaginal photobiomodulation therapy or sham therapy. Treatment will involve 9 planned treatment sessions over 3-4 wee... Read More
Gender:
Female
Ages:
18 years and above
Trial Updated:
09/01/2023
Locations: MedStar Washington Hospital Center, Washington, District of Columbia
Conditions: Endometriosis, Dyspareunia, Pelvic Pain
Register for Updates
Group Visits for High Risk Type 1 Diabetes (T1D)
NCT05431686
Recruiting
The investigators propose to conduct a pilot prospective cohort study to assess the impact of shared medical appointments (SMA) visits in underserved youth with poorly controlled type 1 diabetes (T1D). The trial will employ an enrollment visit, SMA visits every 3 months over a 12 month study period, followed by a 6-month observational period to assess feasibility and acceptability of SMA and the impact on glycemic control, self-management skills, and health related quality of life.
Gender:
All
Ages:
8 years and above
Trial Updated:
08/31/2023
Locations: Children's National Hospital, Washington, District of Columbia
Conditions: Type 1 Diabetes
Register for Updates
Nerivio Device for Treatment of New Daily Headache Persistence (NDHP)
NCT05310227
Recruiting
The goal of this study is to examine the effects of the Remote Electrical Neuromodulation (REN) device on adolescents ages 12-17 who have been diagnosed with New Daily Persistent Headache (NDPH). Pediatric patients with a diagnosis of new daily persistent headache are typically resistant to standard pharmacologic treatments and often experience systemic side effects related to medications; thus, REN offers the potential for an exciting new treatment option for patients with refractory headache d... Read More
Gender:
All
Ages:
Between 12 years and 17 years
Trial Updated:
08/31/2023
Locations: Children's National Medical Center, Washington, District of Columbia
Conditions: New Daily Persistent Headache (NDPH)
Register for Updates
AltaValve Early Feasibility Study Protocol
NCT03997305
Recruiting
Prospective, single-arm, multicenter study to evaluate the safety and performance of the AltaValve for the treatment of moderate to severe or severe mitral valve regurgitation in subjects who are considered high risk for mortality and morbidity from conventional open-heart surgery.
Gender:
All
Ages:
18 years and above
Trial Updated:
08/31/2023
Locations: MedStar Washington Hospital, Washington, District of Columbia
Conditions: Mitral Regurgitation, Mitral Insufficiency, Mitral Valve Incompetence, Mitral Valve Regurgitation, Mitral Incompetence
Register for Updates
Exploring Outcomes and Characteristics of Myasthenia Gravis 2
NCT06002945
Recruiting
The goal of this prospective observational study is to create a network repository of clinical data and biological samples to help researchers learn more about myasthenia gravis.
Gender:
All
Ages:
18 years and above
Trial Updated:
08/28/2023
Locations: George Washington University, Washington, District of Columbia
Conditions: Myasthenia Gravis
Register for Updates
Central Blood Pressure and Pulse Wave Velocity in Kidney Transplant Recipients
NCT04212143
Recruiting
An observational cohort study will be conducted to non-invasively investigate central blood pressure and pulse wave velocity in children with kidney disease and controls. Using an oscillometric monitor, the investigators aim to non-invasively obtain the central blood pressure and pulse wave velocity (PWV), or arterial stiffness, of children with kidney disease. The investigators will also enroll age- and race-matched healthy controls and measure the same parameters for comparison. In addition, t... Read More
Gender:
All
Ages:
Between 3 years and 21 years
Trial Updated:
08/28/2023
Locations: Children's National Medical Cetner, Washington, District of Columbia
Conditions: End Stage Renal Disease
Register for Updates
A Phase 3 Study to Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia
NCT04812925
Recruiting
A Phase 3 study to evaluate the safety and efficacy of efgartigimod PH20 subcutaneous in adult patients with primary immune thrombocytopenia
Gender:
All
Ages:
18 years and above
Trial Updated:
08/25/2023
Locations: Investigator site 0010045, Washington, District of Columbia
Conditions: Primary Immune Thrombocytopenia
Register for Updates
Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex
NCT04677569
Recruiting
The main objective of this study is to evaluate the efficacy of ALIS (amikacin liposome inhalation suspension) + background regimen (azithromycin [AZI] + ethambutol [ETH]) compared to the ELC (empty liposome control) + background regimen on participant-reported respiratory symptoms at Month 13.
Gender:
All
Ages:
18 years and above
Trial Updated:
08/22/2023
Locations: USA023, Washington, District of Columbia
Conditions: Mycobacterium Infections, Nontuberculous
Register for Updates